Internal Medicine, Gastroenterology · Springfield, MO
NPI
1184644064
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2115 S Fremont Ave, Suite 3300
Springfield, MO, 65804
Phone (417) 820-5200
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
835 services
Medicare patients, 2024
451
Average age 72
Drug cost, 2024
$312K
2,034 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel E Brady was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 190 times for 186 patients. In total Daniel E Brady billed 835 services in 42 codes, and Medicare paid $78K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-11.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 190 | 186 | $4.18 | $795 |
| 45385 Colonoscopy - Lesion Removal | Facility | 146 | 146 | $193.96 | $28K |
| 43239 Upper GI Endoscopy | Facility | 106 | 104 | $69.78 | $7,397 |
| 99223 Hospital E&M - Initial | Facility | 49 | 49 | $123.97 | $6,075 |
| 99214 Office E&M - Established | Office | 40 | 36 | $77.63 | $3,105 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 39 | 39 | $151.60 | $5,912 |
| 43235 Upper GI Endoscopy | Facility | 34 | 34 | $68.79 | $2,339 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 32 | 32 | $161.16 | $5,157 |
| 45380 Lower GI Endoscopy - Other | Facility | 27 | 26 | $101.69 | $2,746 |
| 45378 Lower GI Endoscopy - Other | Facility | 23 | 23 | $109.03 | $2,508 |
| 43248 Upper GI Endoscopy | Facility | 19 | 19 | $119.31 | $2,267 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 14 | $55.15 | $938 |
| 43249 Upper GI Endoscopy | Facility | 15 | 15 | $102.75 | $1,541 |
| 43450 Digestive/Gastrointestinal | Facility | 13 | 13 | $29.12 | $379 |
| 43255 Upper GI Endoscopy | Facility | 12 | 11 | $135.65 | $1,628 |
By year: 2022 $99K for 989 services; 2023 $71K for 746 services; 2024 $78K for 835 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel E Brady prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 365 prescriptions and refills. In total Daniel E Brady wrote 2,034 Medicare prescriptions that cost $312K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 365 | 365 | 352 | $7,142 |
| Pantoprazole Sodium Generic | 202 | 338 | 68 | $1,797 |
| Famotidine Generic | 150 | 282 | 53 | $1,705 |
| Omeprazole Generic | 132 | 278 | 43 | $919 |
| Metoclopramide Hcl Generic | 111 | 151 | 36 | $607 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 76 | 76 | 75 | $961 |
| Creon Lipase/Protease/Amylase | 71 | 84 | 13 | $149K |
| Dicyclomine Hcl Generic | 65 | 87 | 19 | $1,109 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 64 | 64 | 62 | $852 |
| Gavilyte-N Sodium Chloride/Nahco3/Kcl/Peg | 56 | 56 | 56 | $760 |
| Cholestyramine Cholestyramine (With Sugar) | 53 | 63 | 21 | $3,979 |
| Amitriptyline Hcl Generic | 50 | 78 | Under 11 | $327 |
| Linzess Linaclotide | 49 | 57 | 12 | $30K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 35 | 35 | Under 11 | $903 |
| Ursodiol Generic | 33 | 41 | Under 11 | $5,520 |
Brand drugs: - claims; generic drugs: 1,599 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Daniel E Brady were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.